D.E. Shaw & Co
CLOV icon

D.E. Shaw & Co’s Clover Health Investments CLOV Stock Holding History

D.E. Shaw & Co’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-290,100
Closed -$2.14M – 5439
2021
Q3 		$2.14M Buy
+290,100
New +$2.48M ﹤0.01% 2978

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co's CLOV Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Clover Health Investments (CLOV) stake by 68% in Q1 2026, selling an estimated $416K and leaving 91,011 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #4234.

D.E. Shaw & Co first reported a position in CLOV in Q3 2020 and has held it in 15 quarters since. The position peaked at $13.7M in Q1 2022. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • D.E. Shaw & Co held 91,011 shares of Clover Health Investments worth $160K as of Q1 2026.
  • D.E. Shaw & Co sold 191,679 Clover Health Investments shares in Q1 2026, an estimated $416K.
  • Clover Health Investments made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4234 holding.
  • D.E. Shaw & Co first reported a position in Clover Health Investments in Q3 2020 and has held it in 15 quarters since.
  • D.E. Shaw & Co's Clover Health Investments position peaked at $13.7M in Q1 2022.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.